risvutatug rezetecan   Click here for help

GtoPdb Ligand ID: 14693

Synonyms: GSK'227 | GSK5764227 | HS-20093 | Ris-Rez
Compound class: Antibody
Comment: Risvutatug rezetecan (GSK5764227, formerly HS-20093; Ris-Rez) is an antibody-drug congugate that targets a camptothecin derived topoisomerase I inhibitor to (tumour) cells expressing CD276 (B7-H3) [2-3,5]. Peptide sequences for risvutatug's heavy and light chains are claimed in Hansoh patent US10899837B2, and these form the antibody named h1702 therein [4].
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
13784 risvutatug rezetecan
Synonyms Click here for help
GSK'227 | GSK5764227 | HS-20093 | Ris-Rez
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1890
Other databases
GtoPdb PubChem SID 530846941
Search PubMed clinical trials risvutatug rezetecan
Search PubMed titles risvutatug rezetecan
Search PubMed titles/abstracts risvutatug rezetecan